Pengembangan Aplikasi Seluler Kesehatan Terkait Diabetes Melitus

Authors

  • Johan Indra Lukito Medical Department, PT. Kalbe Farma Tbk., Jakarta, Indonesia

DOI:

https://doi.org/10.55175/cdk.v48i10.140

Keywords:

teknologi seluler, DM, diabetes, aplikasi

Abstract

Peningkatan kualitas hidup pasien diabetes melitus (DM) membutuhkan pengelolaan komprehensif. Beberapa tantangan dihadapi baik oleh pasien maupun profesional kesehatan dalam tatalaksana DM. Penggunaan dan pengembangan aplikasi seluler kesehatan berbasis telemedicine dan teknologi informasi kesehatan diharapkan dapat membantu mengatasi tantangan ini.

Improving the quality of life of patients with diabetes mellitus (DM) requires comprehensive management. Several challenges are faced by both patients and health professionals in the management of DM. It is hoped that the use and development of mobile health applications based on telemedicine and health information technology can help overcome this challenge.Johan Indra Lukito. Development of Diabetes Mellitus Mobile Health Applications.

Downloads

References

PERKENI. Pedoman pengelolaan DM tipe 2 dewasa di Indonesia 2019. Jakarta: PERKENI; 2019.

Drincic A, Prahalad P, Greenwood D, Klonoff DC. Evidence-based mobile medical applications in diabetes. Endocrinol Metab Clin North Am. 2016;45(4):943-65.

Vehi J, RegincósIsern J, Parcerisas A, Calm R, Contreras I. Impact of use frequency of a mobile diabetes management app on blood glucose control: Evaluation study. JMIR Mhealth Uhealth. 2019;7(3):11933.

Adu MD, Malabu UH, Malau-Aduli AE, Drovandi A, Malau-Aduli BS. User retention and engagement with a mobile app intervention to support self-management in Australians with type 1 or type 2 diabetes (My Care Hub): Mixed methods study. JMIR Mhealth Uhealth. 2020;8(6):17802.

Zhang Y, Li X, Luo S, Liu C, Xie Y, Guo J, et al. Use, perspectives, and attitudes regarding diabetes management mobile apps among diabetes patients and diabetologists in China: National web-based survey. JMIR Mhealth Uhealth. 2019;7(2):12658.

American Diabetes Association 4. Lifestyle management: Standards of medical care in diabetes-2018. Diabetes Care. 2018;41(Suppl 1):38–50. doi: 10.2337/dc18-S004.

Arthur M. Triabetes: Your diabetes all-in-one app. Nurs Stand. 2014;28(44):35.

mySugr [Internet]. 2020 [cited 2020 November 16]. Available from https://www.mysugr.com/en/about-us

Debong F, Mayer H, Kober J. Real-world assessments of mySugr mobile health app. Diabetes Technol Ther. 2019;21:2, 2-35-2-40

Hompesch M, Kalcher K, Debong F. High risk population using mobile logging application shows significant reduction in LBGI [Internet]. 2020 [cited 2020 November 16]. Available from: https://www.mysugr.com/static/assets/downloads/science_and_research/ada-2017-poster.pdf

Quinn C, Shardell M, Terrin M, Barr EA, Ballew SH, Gruber-Baldini AL. Cluster-randomized trial of a mobile phone personalized behavioral intervention for blood glucose control. Diabetes Care 2011;34(9):1934–42. [PubMed: 21788632]

Charpentier G, Benhamou P, Dardari D, Clergeot A, Franc S, Schaepelynck-Belicar P, et al. The diabeo software enabling individualized insulin dose adjustments combined with telemedicine support improves HbA1c in poorly controlled type 1 diabetic patients: A 6-month, randomized, open-label, parallel-group, multicenter trial (TeleDiab 1 Study). Diabetes Care 2011;34(3):533–9. [PubMed: 21266648]

Franc S, Borot S, Ronsin O, Quesada JL, Dardari D, Fagour C, et al. Telemedicine and type 1 diabetes: Is technology per se sufficient to improve glycaemic control? Diabetes Metab. 2014;40(1):61-6.

Quinn C, Khokhar B, Weed K, Barr E, Gruber-Baldini AL. Older adult self-efficacy study of mobile phone diabetes management. Diabetes Technol Ther. 2015;17(7):455–61. [PubMed: 25692373]

Franc S, Dardari D, Biedzinski M, Requeda E, Canipel L, Hochberg G, et al. Type 1 diabetes: Dealing with physical activity. Diabetes Metab. 2012;38(5):466–9. [PubMed: 22705014]

Barnard K, Parkin C, Young A, Ashraf M. Use of an automated bolus calculator reduces fear of hypoglycemia and improves confidence in dosage accuracy in patients with type 1 diabetes mellitus treated with multiple daily insulin injections. J Diabetes Sci Technol. 2012; 6(1):144–9. [PubMed: 22401332]

Rossi M, Nicolucci A, Bartolo P, Bruttomesso D, Girelli A, Ampudia FJ, et al. Diabetes interactive diary: A new telemed-icine system enabling flexible diet and insulin therapy while improving quality of life an open-label, international, multicenter, randomized study. Diabetes Care 2010; 33(1):109–15. [PubMed: 19808926]

Rossi M, Nicolucci A, Lucisano G, Pellegrini F, Bartolo D, Miselli V, et al. Impact of the “diabetes interactive diary” telemedicine system on metabolic control, risk of hypoglycemia, and quality of life: A randomized clinical trial in type 1 diabetes. Diabetes Technol Ther. 2013;15(8):670–9. [PubMed: 23844569]

Javitt JC, Reese CS, Derrick MK. Deployment of anmHealth patient monitoring solution for diabetes—improved glucose monitoring leads to reduction in medical expenditure. US Endocrinol. 2013;9(2):119–23.

Greenwood DA, Young HM, Quinn CC. Telehealth remote monitoring systematic review: Structured self-monitoring of blood glucose and impact on HbA1c. J Diabetes Sci Technol. 2014;8(2):378–89. [PubMed: 24876591]

Ziegler R, Cavan D, Cranston I, Barnard K, Ryder J, Vogel C, et al. Use of an insulin bolus advisor improves glycemic control in multiple daily insulin injection (MDI) therapy patients with suboptimal glycemic control: First results from the ABACUS trial. Diabetes Care 2013;36(11):3613–9. [PubMed: 23900590]

Charpentier G, Benhamou P, Dardari D, Clergeot A, Franc S, Schaepelynck-Belicar P, et al. The Diabeo software enabling individualized insulin dose adjustments combined with telemedicine support improves HbA1c in poorly controlled type 1 diabetic patients: A 6-month, randomized, open-label, parallel-group, multicenter trial (TeleDiab 1 Study). Diabetes Care 2011; 34(3):533–9. [PubMed: 21266648]

US Department of Health and Human Services. Food and Drug Administration center for drug evaluation and research (CDER) [Internet]. [cited 2016 March 22] Available at: http://www.fda.gov/downloads/Drugs/.../Guidances/ucm071624.pdf

Quinn CC, Shardell MD, Terrin ML, Barr EA, Ballew SH, Gruber-Baldini AL. Cluster-randomized trial of a mobile phone personalized behavioral intervention for blood glucose control. Diabetes Care 2011;34(9):1934-42.

Downloads

Published

01-10-2021

How to Cite

Lukito, J. I. (2021). Pengembangan Aplikasi Seluler Kesehatan Terkait Diabetes Melitus. Cermin Dunia Kedokteran, 48(10), 422–425. https://doi.org/10.55175/cdk.v48i10.140